EPB41L1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.846500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.719220E-01
Normal-vs-Stage2
8.316000E-02
Normal-vs-Stage3
3.569000E-01
Normal-vs-Stage4
4.942200E-02
Stage1-vs-Stage2
4.216600E-01
Stage1-vs-Stage3
9.067400E-01
Stage1-vs-Stage4
1.474050E-01
Stage2-vs-Stage3
4.439600E-01
Stage2-vs-Stage4
5.319000E-01
Stage3-vs-Stage4
2.451800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.853900E-02
Normal-vs-AfricanAmerican
2.339200E-01
Normal-vs-Asian
1.023610E-01
Caucasian-vs-AfricanAmerican
8.030600E-01
Caucasian-vs-Asian
6.129000E-01
AfricanAmerican-vs-Asian
6.185400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.075600E-02
Normal-vs-Female
1.056450E-01
Male-vs-Female
7.427700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.031600E-01
Normal-vs-Age(41-60Yrs)
3.885700E-02
Normal-vs-Age(61-80Yrs)
1.422840E-01
Normal-vs-Age(81-100Yrs)
6.853600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.396200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.852200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.586800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.570200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.165800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.893200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.514190E-01
Normal-vs-Daily Drinker
1.135970E-01
Normal-vs-Weekly Drinker
2.409600E-01
Normal-vs-Occasional Drinker
3.999700E-02
Normal-vs-Social Drinker
4.897700E-02
Non Drinker-vs-Daily Drinker
5.107400E-01
Non Drinker-vs-Weekly Drinker
6.886800E-01
Non Drinker-vs-Occasional Drinker
3.203800E-01
Non Drinker-vs-Social Drinker
4.326800E-01
Daily Drinker-vs-Weekly Drinker
3.725800E-01
Daily Drinker-vs-Occasional Drinker
7.716800E-01
Daily Drinker-vs-Social Drinker
1.690640E-01
Weekly Drinker-vs-Occasional Drinker
2.148200E-01
Weekly Drinker-vs-Social Drinker
8.734800E-01
Occasional Drinker-vs-Social Drinker
6.427600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.163970E-01
Normal-vs-Grade 2
1.956390E-02
Normal-vs-Grade 3
1.371740E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.236000E-03
Grade 1-vs-Grade 3
9.193500E-04
Grade 1-vs-Grade 4
1.163970E-01
Grade 2-vs-Grade 3
4.531800E-01
Grade 2-vs-Grade 4
1.956390E-02
Grade 3-vs-Grade 4
1.371740E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.096200E-01
Normal-vs-NonDiabetic
6.127600E-02
Diabetic-vs-NonDiabetic
2.040400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.987500E-02
Normal-vs-NoPancreatitis
1.013600E-01
Pancreatitis-vs-NoPancreatitis
1.784560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.008980E-01
Normal-vs-N1
8.152100E-02
N0-vs-N1
3.013400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.433750E-02
Normal-vs-TP53-NonMutant
3.309400E-01
TP53-Mutant-vs-TP53-NonMutant
7.54160000004944E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
